Meisetschläger G - Search Results

Year	Number of Results
2001	1
2002	1
2003	1
2005	2
2006	5
2007	2
2009	1
2010	2
2015	1
2024	0

1

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Zohlnhöfer D, Ott I, Mehilli J, Schömig K, Michalk F, Ibrahim T, Meisetschläger G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schömig A; REVIVAL-2 Investigators. Zohlnhöfer D, et al. Among authors: meisetschlager g. JAMA. 2006 Mar 1;295(9):1003-10. doi: 10.1001/jama.295.9.1003. JAMA. 2006. PMID: 16507801 Clinical Trial.

2

[Nuclear medical diagnostics for liver tumors].

Buck AK, Stollfuss JC, Stahl A, Beer AJ, Meisetschläger G, Schwaiger M. Buck AK, et al. Among authors: meisetschlager g. Internist (Berl). 2007 Jan;48(1):21-4, 26-9. doi: 10.1007/s00108-006-1769-6. Internist (Berl). 2007. PMID: 17195061 German.

3

Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature.

Negele T, Meisetschläger G, Brückner T, Scheidhauer K, Schwaiger M, Vogelsang H. Negele T, et al. Among authors: meisetschlager g. Langenbecks Arch Surg. 2006 Jun;391(3):178-86. doi: 10.1007/s00423-005-0013-5. Epub 2006 Feb 21. Langenbecks Arch Surg. 2006. PMID: 16491404 Review.

4

PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.

Wester HJ, Schottelius M, Scheidhauer K, Meisetschläger G, Herz M, Rau FC, Reubi JC, Schwaiger M. Wester HJ, et al. Among authors: meisetschlager g. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):117-22. doi: 10.1007/s00259-002-1012-1. Epub 2002 Nov 5. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483418

5

Positron detection for the intraoperative localisation of cancer deposits.

Piert M, Burian M, Meisetschläger G, Stein HJ, Ziegler S, Nährig J, Picchio M, Buck A, Siewert JR, Schwaiger M. Piert M, et al. Among authors: meisetschlager g. Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1534-44. doi: 10.1007/s00259-007-0430-5. Epub 2007 Apr 12. Eur J Nucl Med Mol Imaging. 2007. PMID: 17431612 Free PMC article. Clinical Trial.

6

Not all DTC patients with N positive disease deserve the attribution "high risk". Contribution of the MSDS trial.

Vrachimis A, Wenning C, Gerß J, Dralle H, Vaez Tabassi M, Schober O, Riemann B; MSDS study group. Vrachimis A, et al. J Surg Oncol. 2015 Jul;112(1):9-14. doi: 10.1002/jso.23948. Epub 2015 Jun 12. J Surg Oncol. 2015. PMID: 26074402 Clinical Trial.

7

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.

Weber WA, Ott K, Becker K, Dittler HJ, Helmberger H, Avril NE, Meisetschläger G, Busch R, Siewert JR, Schwaiger M, Fink U. Weber WA, et al. Among authors: meisetschlager g. J Clin Oncol. 2001 Jun 15;19(12):3058-65. doi: 10.1200/JCO.2001.19.12.3058. J Clin Oncol. 2001. PMID: 11408502

8

Primary tumour size is a prognostic parameter in patients suffering from differentiated thyroid carcinoma with extrathyroidal growth: results of the MSDS trial.

Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, Lerch H, Gerss J, Frankewitsch T, Schober O, Riemann B; MSDS study group. Krämer JA, et al. Eur J Endocrinol. 2010 Oct;163(4):637-44. doi: 10.1530/EJE-10-0116. Epub 2010 Jul 21. Eur J Endocrinol. 2010. PMID: 20660003 Clinical Trial.

9

Clinical outcomes of adjuvant external-beam radiotherapy for differentiated thyroid cancer - results after 874 patient-years of follow-up in the MSDS-trial.

Biermann M, Pixberg M, Riemann B, Schuck A, Heinecke A, Schmid KW, Willich N, Dralle H, Schober O; MSDS study group. Biermann M, et al. Nuklearmedizin. 2009;48(3):89-98; quiz N15. doi: 10.3413/nukmed-0221. Epub 2009 Mar 23. Nuklearmedizin. 2009. PMID: 19322503 Clinical Trial.

10

Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial.

Riemann B, Krämer JA, Schmid KW, Dralle H, Dietlein M, Schicha H, Sauerland C, Frankewitsch T, Schober O; MSDS study group. Riemann B, et al. Nuklearmedizin. 2010;49(3):79-84. doi: 10.3413/nukmed-0302. Nuklearmedizin. 2010. PMID: 20505894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year